Patients who suffered AKI had significantly higher levels of IL-17A than those who did not have AKI at both timepoints: T1 1918.6 fg/ml (692.0–5860.9) versus 623.1 fg/ml (331.7–1503.4), p < 0.001; T2 2167.7 fg/ml (839.9–4618.9) versus 1193.5 fg/ml (523.8–2198.7), p = 0.006. The gene discussed is IL17A; the disease is acute kidney injury.